The first healthcare and life sciences strategic advisory & investment banking firm founded by leading US investors and global executives to deliver transformative industry growth.
THE BUSINESS NEED
Emerging markets represent an exceptional opportunity for the pharmaceutical industry.
Between 2015 and 2020, pharma sales growth estimates scored higher in emerging countries than in developed countries, with BRIC-MT countries ranking first with a 9.3% growth in sales.
Emerging countries are solid markets for drug formulae that have been selling for decades. This significantly boosts the chances of succeeding in launching new products tailored especially for these markets.
*SOURCE: Current Therapeutic Research; The Influence of Emerging Markets on the Pharmaceutical Industry, 2017.
WHAT WE DO
R&D and Commercial Alliances
Investments & Corporate Financing
Global Healthcare Innovation Policy
Market Access &
Public Private Partnerships